Avidity Biosciences, Inc. Common Stock
Symbol: RNA (NASDAQ)
48.50
▼ (-0.10%) -0.049
Company Description:
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Key Stats
- Today's Open: $48.99
- Today's High: $50.19
- Today's Low: $48.25
- Today's Volume: 1.27M
- Yesterday Close: $48.55
- Yesterday High: $49.0899
- Yesterday Low: $46.37
- Yesterday Volume: 926.62K
- Last Min Volume: 0
- Last Min High: $48.809
- Last Min Low: $48.501
- Last Min VWAP: $0
Company Profile
- Name: Avidity Biosciences, Inc. Common Stock
- Website: https://www.aviditybiosciences.com
- Listed Date: 2020-06-12
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001599901
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.17B
- Round Lot: 100
- Outstanding Shares: 145.90M
- Asset Type: CS
RECENT FILINGS FOR RNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-24 | 4 | View |
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-17 | 4 | View |
| 2025-10-14 | 8-K | View |
| 2025-10-07 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-12 | 8-K | View |
| 2025-09-12 | 424B5 | View |
| 2025-09-12 | 4 | View |
| 2025-09-11 | 144 | View |
| 2025-09-10 | 424B5 | View |
| 2025-09-10 | 8-K | View |
| 2025-09-09 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-05 | 144 | View |
| 2025-09-03 | 144 | View |
Latest News on RNA